Pharmafile Logo

Peter Impey

- PMLiVE

Death of a salesman

Will people communicate the same way if their results are not being measured?

- PMLiVE

Pfizer recalls depression drug in US

Wrong medicine found in bottle of Effexor XR

EU flag

J&J gets EU green light for novel TB drug

Sirturo approved to treat multidrug resistant form of the disease

Novartis building

Novartis’ dermatology plans advance with Xolair approval

Green light for use in chronic spontaneous urticaria

Patients and HCPs turn first to Wikipedia

The online encyclopedia is now the leading source of medical information

- PMLiVE

Diabetes awards programme launches

QiC Diabetes 2014 premiered at Diabetes UK conference

INC Research acquires Middle Eastern CRO

Purchase of MEK Consulting expands its geographic footprint

Stallergenes appoints Christian Chavy CEO

He will replace Roberto Gradnik at the end of this month

Bristol-Myers Squibb (BMS) building

BMS’ novel HIV drug clears phase II trial

Entry inhibitor BMS-660368 moves closer to first-in-class approval

- PMLiVE

Lilly/Boehringer’s empagliflozin faces US approval delay

FDA cites manufacturing issues with the new diabetes drug

- PMLiVE

New VP for Merz North America

Gregory Bass to lead market access and reimbursement strategy

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links